Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Extends Offer for Beckman Coulter for Third Time

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher on Tuesday extended for a third time its cash tender offer for Beckman Coulter.

The offer to acquire all outstanding shares of Beckman Coulter is now set to expire on June 24, 5 p.m., New York City time. It had been scheduled to expire at midnight June 6.

The company said that it anticipates regulatory approval of the $6.8 billion deal from the European Commission on or about June 16, and to close on it before the end of June. As of 4 p.m. on May 31, more than 25 million shares of Beckman Coulter's stock had been validly tendered and not withdrawn, Danaher said.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.